medigraphic.com
ISSN 1729-6935 (Digital)
16 de abril

2022, Número 285

<< Anterior

16 de abril 2022; 61 (285)


Implications of physiological changes in pregnancy in COVID-19

Rosales-Campos RD, Pérez-Hernández HJ, Acosta-Brooks SC

Idioma: Español
Referencias bibliográficas: 10
Paginas: 1-6
Archivo PDF: 299.63 Kb.


RESUMEN

Pregnant women generally constitute a group at high risk of infectious diseases due to gestational immunological and physiological changes in their system. That is why the objective of this work is to explain the implications of the physiological changes of pregnancy in SARS-CoV-2 disease. Physiological changes in pregnant women not only increase their susceptibility to the virus, but also increase the severity of the disease. Changes in the respiratory and immune systems, the role of the placenta in coagulation, and the function of endothelial cells are the physiological changes that most influence the disease. The decrease in lung capacity and the variations that occur in the immune system represent new treatment challenges for pregnant women with COVID-19 disease and therefore new areas of research limited so far.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Rajewska A, Mikołajek-Bedner W,Lebdowicz-Knul J, Sokołowska M,Kwiatkowski S, Torbé A. COVID-19and pregnancy - where are we now?A review. J Perinat Med [Internet]. 2020 [cited 02/08/2021]; 48(5):428-34. Available from: https://pubmed.ncbi.nlm.nih.gov/32452195/

  2. Zhao X, Jiang Y, Zhao Y, Xi H,Liu C, Qu F, et al. Analysis of thesusceptibility to COVID-19 inpregnancy and recommendations onpotential drug screening. Eur J ClinMicrobiol Infect Dis [Internet]. 2020[cited 02/08/2021]; 39(7):1209-20.Available from: https://pubmed.ncbi.nlm.nih.gov/32328850/

  3. Thompson JL, Nguyen LM, NobleKN, Aronoff DM. COVID-19-relateddisease severity in pregnancy. AmJ Reprod Immunol [Internet]. 2020[cited 02/08/2021]; 84(5):e13339.Available from: https://pubmed.ncbi.nlm.nih.gov/32885539/ .

  4. Wastnedge EAN, Reynolds RM,van Boeckel SR, Stock SJ, DenisonFC, Maybin JA, et al. Pregnancy andCOVID-19. Physiol Rev [Internet].2021 [cited 02/08/2021]; 101(1):303-18. Available from: https://pubmed.ncbi.nlm.nih.gov/32969772/

  5. Di Mascio D, Sen C, SacconeG, Galindo A, Grünebaum A,Yoshimatsu J, et al. Risk factorsassociated with adverse fetaloutcomes in pregnancies affectedby Coronavirus disease 2019(COVID-19): a secondary analysisof the WAPM study on COVID-19.J Perinat Med [Internet]. 2020[cited 02/08/2021]; 48(9):950-58.Available from: https://pubmed.ncbi.nlm.nih.gov/32975205/

  6. Chilipio-Chiclla MA, Campos-Correa KE. Manifestaciones clínicasy resultados materno-perinatalesdel COVID-19 asociado al embarazo:Una revisión sistemática. Rev Inter Sal Mat Fet [Internet]. 2020 [cited02/08/2021]; 5(2):24-37. Disponibleen: http://ojs.revistamaternofetal.com/index.php/RISMF/article/view/181

  7. Muyayalo KP, Huang DH,Zhao SJ, Xie T, Mor G, LiaoAH. COVID-19 and Treg / Th17imbalance: Potential relationshipto pregnancy outcomes. Am JReprod Immunol[Internet]. 2020[cited 02/08/2021]; 84(5):e13304.Available from: https://pubmed.ncbi.nlm.nih.gov/32662111/

  8. Wenling Y, Junchao Q, Xiao Z,Ouyang S. Pregnancy and COVID-19:management and challenges. RevInst Med Trop Sao Paulo [Internet].2020 [cited 02/08/2021]; 62:e62.Available from: https://pubmed.ncbi.nlm.nih.gov/32876296/

  9. Salem D, Katranji F, BakdashT. Covid-19 infection in pregnantwomen: Review of maternaland fetal outcomes. Int. J.Gynecol. Obstet [Internet]. 2021[cited 02/08/2021]; 152(3):291-8. Available from: https://doi.org/10.1002/ijgo.13533

  10. Prochaska E, Jang M, Burd I.COVID-19 in pregnancy: Placentaland neonatal involvement. Am JReprod Immunol [Internet]. 2020[cited 02/08/2021]; 84(5):e13306.Available from: https://pubmed.ncbi.nlm.nih.gov/32779810/




2020     |     www.medigraphic.com